Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

The association between nicotine dependence and physical health among people receiving injectable diacetylmorphine or hydromorphone for the treatment of chronic opioid use disorder.

Palis H, Marchand K, Karamouzian M, MacDonald S, Harrison S, Guh D, Lock K, Brissette S, Anis AH, Krausz M, Marsh DC, Schechter MT, Oviedo-Joekes E.

Addict Behav Rep. 2018 Mar 27;7:82-89. doi: 10.1016/j.abrep.2018.03.005. eCollection 2018 Jun.

2.

Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial.

Bansback N, Guh D, Oviedo-Joekes E, Brissette S, Harrison S, Janmohamed A, Krausz M, MacDonald S, Marsh DC, Schechter MT, Anis AH.

Addiction. 2018 Jul;113(7):1264-1273. doi: 10.1111/add.14171. Epub 2018 Mar 28.

PMID:
29589873
3.

The relationship between sense of community belonging and self-rated mental health among Canadians with mental or substance use disorders.

Palis H, Marchand K, Oviedo-Joekes E.

J Ment Health. 2018 Feb 12:1-8. doi: 10.1080/09638237.2018.1437602. [Epub ahead of print]

PMID:
29431529
4.

Our Life Depends on This Drug: Competence, Inequity, and Voluntary Consent in Clinical Trials on Supervised Injectable Opioid Assisted Treatment.

Steel D, Marchand K, Oviedo-Joekes E.

Am J Bioeth. 2017 Dec;17(12):32-40. doi: 10.1080/15265161.2017.1388449.

PMID:
29148954
5.

Collaborative Efforts With Opioid Users to Promote Competence and Voluntariness in Clinical Trials With Injectable Opioid Assisted Treatment.

Marchand K, Steel D, Oviedo-Joekes E.

Am J Bioeth. 2017 Dec;17(12):W1-W3. doi: 10.1080/15265161.2017.1398281. No abstract available.

PMID:
29148948
6.

Canada Is in Urgent Need to Expand Opioid Agonist Treatment.

Oviedo-Joekes E.

Can J Psychiatry. 2017 Jul;62(7):442-443. doi: 10.1177/0706743716672408. No abstract available.

7.

Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long-term opioid dependence.

Oviedo-Joekes E, Palis H, Guh D, Marchand K, Brissette S, Lock K, MacDonald S, Harrison S, Anis AH, Krausz M, Marsh DC, Schechter MT.

Drug Alcohol Rev. 2018 Jan;37(1):137-146. doi: 10.1111/dar.12573. Epub 2017 Jun 8.

PMID:
28593748
8.

Men's and women's response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder.

Palis H, Marchand K, Guh D, Brissette S, Lock K, MacDonald S, Harrison S, Anis AH, Krausz M, Marsh DC, Schechter MT, Oviedo-Joekes E.

Subst Abuse Treat Prev Policy. 2017 May 19;12(1):25. doi: 10.1186/s13011-017-0110-9.

9.

Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorder.

Oviedo-Joekes E, Brissette S, MacDonald S, Guh D, Marchand K, Jutha S, Harrison S, Janmohamed A, Zhang DZ, Anis AH, Krausz M, Marsh DC, Schechter MT.

Drug Alcohol Depend. 2017 Jul 1;176:55-62. doi: 10.1016/j.drugalcdep.2017.02.021. Epub 2017 May 10.

PMID:
28521199
10.

The Role of Gender in Suicidal Ideation among Long-term Opioid Users.

Marchand K, Palis H, Fikowski J, Harrison S, Spittal P, Schechter MT, Oviedo-Joekes E.

Can J Psychiatry. 2017 Jul;62(7):465-472. doi: 10.1177/0706743717711173. Epub 2017 May 18.

11.

Prioritizing the patient in patient-centered addictions treatment.

Marchand K, Oviedo-Joekes E.

Addiction. 2017 Mar;112(3):466-467. doi: 10.1111/add.13680. No abstract available.

PMID:
28168794
12.

Optimal threshold for birth weight discordance: Does knowledge of chorionicity matter?

Jahanfar S, Lim K, Oviedo-Joekes E.

J Perinatol. 2016 Sep;36(9):704-12. doi: 10.1038/jp.2016.82. Epub 2016 May 12.

PMID:
27171760
13.

Factors Associated with Perceived Abuse in the Health Care System Among Long-Term Opioid Users: A Cross-Sectional Study.

Palis H, Marchand K, Peng D, Fikowski J, Harrison S, Spittal P, Schechter MT, Oviedo-Joekes E.

Subst Use Misuse. 2016 May 11;51(6):763-76. doi: 10.3109/10826084.2016.1155605. Epub 2016 Apr 20.

PMID:
27096889
14.

Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence: A Randomized Clinical Trial.

Oviedo-Joekes E, Guh D, Brissette S, Marchand K, MacDonald S, Lock K, Harrison S, Janmohamed A, Anis AH, Krausz M, Marsh DC, Schechter MT.

JAMA Psychiatry. 2016 May 1;73(5):447-55. doi: 10.1001/jamapsychiatry.2016.0109.

PMID:
27049826
15.

The Cedar Project: resilience in the face of HIV vulnerability within a cohort study involving young Indigenous people who use drugs in three Canadian cities.

Pearce ME, Jongbloed KA, Richardson CG, Henderson EW, Pooyak SD, Oviedo-Joekes E, Christian WM, Schechter MT, Spittal PM; Cedar Project Partnership.

BMC Public Health. 2015 Oct 29;15:1095. doi: 10.1186/s12889-015-2417-7.

16.

Patient Perceptions of Prejudice and Discrimination by Health Care Providers and its Relationship with Mental Disorders: Results from the 2012 Canadian Community Health-Mental Health Survey Data.

Marchand K, Palis H, Oviedo-Joekes E.

Community Ment Health J. 2016 Apr;52(3):294-301. doi: 10.1007/s10597-015-9949-2. Epub 2015 Sep 26.

PMID:
26410218
17.

The Role of Gender in Factors Associated With Addiction Treatment Satisfaction Among Long-Term Opioid Users.

Marchand K, Palis H, Peng D, Fikowski J, Harrison S, Spittal P, Schechter MT, Oviedo-Joekes E.

J Addict Med. 2015 Sep-Oct;9(5):391-8. doi: 10.1097/ADM.0000000000000145.

18.

Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction†.

Strang J, Groshkova T, Uchtenhagen A, van den Brink W, Haasen C, Schechter MT, Lintzeris N, Bell J, Pirona A, Oviedo-Joekes E, Simon R, Metrebian N.

Br J Psychiatry. 2015 Jul;207(1):5-14. doi: 10.1192/bjp.bp.114.149195. Review.

19.

The Cedar Project: Residential transience and HIV vulnerability among young Aboriginal people who use drugs.

Jongbloed K, Thomas V, Pearce ME, Christian KW, Zhang H, Oviedo-Joekes E, Schechter MT, Spittal PM; Cedar Project Partnership.

Health Place. 2015 May;33:125-31. doi: 10.1016/j.healthplace.2015.02.008. Epub 2015 Apr 2.

PMID:
25840350
20.

The SALOME study: recruitment experiences in a clinical trial offering injectable diacetylmorphine and hydromorphone for opioid dependency.

Oviedo-Joekes E, Marchand K, Lock K, MacDonald S, Guh D, Schechter MT.

Subst Abuse Treat Prev Policy. 2015 Jan 26;10:3. doi: 10.1186/1747-597X-10-3.

21.

Feasibility of applying the life history calendar in a population of chronic opioid users to identify patterns of drug use and addiction treatment.

Fikowski J, Marchand K, Palis H, Oviedo-Joekes E.

Subst Abuse. 2014 Oct 29;8:73-8. doi: 10.4137/SART.S19419. eCollection 2014.

22.

Predictors of non-use of illicit heroin in opioid injection maintenance treatment of long-term heroin dependence.

Oviedo-Joekes E, Sordo L, Guh D, Marsh DC, Lock K, Brissette S, Anis AH, Schechter MT.

Addict Behav. 2015 Feb;41:81-6. doi: 10.1016/j.addbeh.2014.10.003. Epub 2014 Oct 7.

23.

A chance to stop and breathe: participants' experiences in the North American Opiate Medication Initiative clinical trial.

Oviedo-Joekes E, Marchand K, Lock K, Chettiar J, Marsh DC, Brissette S, Anis AH, Schechter MT.

Addict Sci Clin Pract. 2014 Sep 29;9:21. doi: 10.1186/1940-0640-9-21.

24.

Differential long-term outcomes for voluntary and involuntary transition from injection to oral opioid maintenance treatment.

Oviedo-Joekes E, Guh D, Marchand K, Marsh DC, Lock K, Brissette S, Anis AH, Schechter MT.

Subst Abuse Treat Prev Policy. 2014 Jun 8;9:23. doi: 10.1186/1747-597X-9-23.

25.

A critical analysis of user satisfaction surveys in addiction services: opioid maintenance treatment as a representative case study.

Trujols J, Iraurgi I, Oviedo-Joekes E, Guàrdia-Olmos J.

Patient Prefer Adherence. 2014 Jan 21;8:107-17. doi: 10.2147/PPA.S52060. eCollection 2014.

26.

Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment.

Nosyk B, Guh DP, Bansback NJ, Oviedo-Joekes E, Brissette S, Marsh DC, Meikleham E, Schechter MT, Anis AH.

CMAJ. 2012 Apr 3;184(6):E317-28. doi: 10.1503/cmaj.110669. Epub 2012 Mar 12.

27.

Sex work involvement among women with long-term opioid injection drug dependence who enter opioid agonist treatment.

Marchand K, Oviedo-Joekes E, Guh D, Marsh DC, Brissette S, Schechter MT.

Harm Reduct J. 2012 Jan 25;9:8. doi: 10.1186/1477-7517-9-8.

28.

Potency ratio of hydromorphone and diacetylmorphine in substitution treatment for long-term opioid dependency.

Oviedo-Joekes E, Marsh DC, Guh D, Brissette S, Schechter MT.

J Opioid Manag. 2011 Sep-Oct;7(5):371-6.

PMID:
22165036
29.

Client satisfaction among participants in a randomized trial comparing oral methadone and injectable diacetylmorphine for long-term opioid-dependency.

Marchand KI, Oviedo-Joekes E, Guh D, Brissette S, Marsh DC, Schechter MT.

BMC Health Serv Res. 2011 Jul 26;11:174. doi: 10.1186/1472-6963-11-174.

30.

Health related quality of life trajectories of patients in opioid substitution treatment.

Nosyk B, Guh DP, Sun H, Oviedo-Joekes E, Brissette S, Marsh DC, Schechter MT, Anis AH.

Drug Alcohol Depend. 2011 Nov 1;118(2-3):259-64. doi: 10.1016/j.drugalcdep.2011.04.003. Epub 2011 May 4.

PMID:
21546173
31.

The Cedar Project: methadone maintenance treatment among young Aboriginal people who use opioids in two Canadian cities.

Yang J, Oviedo-Joekes E, Christian KW, Li K, Louie M, Schechter M, Spittal P.

Drug Alcohol Rev. 2011 Nov;30(6):645-51. doi: 10.1111/j.1465-3362.2010.00258.x. Epub 2011 Jan 5.

PMID:
21355933
32.

History of reported sexual or physical abuse among long-term heroin users and their response to substitution treatment.

Oviedo-Joekes E, Marchand K, Guh D, Marsh DC, Brissette S, Krausz M, Anis A, Schechter MT.

Addict Behav. 2011 Jan-Feb;36(1-2):55-60. doi: 10.1016/j.addbeh.2010.08.020. Epub 2010 Sep 19.

PMID:
20855171
33.

Characteristics and response to treatment among Aboriginal people receiving heroin-assisted treatment.

Oviedo-Joekes E, Guh D, Marsh DC, Brissette S, Nosyk B, Krausz M, Anis A, Christian WM, Spittal P, Schechter MT.

Can J Public Health. 2010 May-Jun;101(3):210-2.

PMID:
20737811
34.

Effectiveness of diacetylmorphine versus methadone for the treatment of opioid dependence in women.

Oviedo-Joekes E, Guh D, Brissette S, Marchand K, Marsh D, Chettiar J, Nosyk B, Krausz M, Anis A, Schechter MT.

Drug Alcohol Depend. 2010 Sep 1;111(1-2):50-7. doi: 10.1016/j.drugalcdep.2010.03.016. Epub 2010 May 26.

PMID:
20510551
35.

The effect of motivational status on treatment outcome in the North American Opiate Medication Initiative (NAOMI) study.

Nosyk B, Geller J, Guh DP, Oviedo-Joekes E, Brissette S, Marsh DC, Schechter MT, Anis AH.

Drug Alcohol Depend. 2010 Sep 1;111(1-2):161-5. doi: 10.1016/j.drugalcdep.2010.03.019. Epub 2010 May 26.

PMID:
20510549
36.

Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: a pilot study.

Oviedo-Joekes E, Guh D, Brissette S, Marsh DC, Nosyk B, Krausz M, Anis A, Schechter MT.

J Subst Abuse Treat. 2010 Jun;38(4):408-11. doi: 10.1016/j.jsat.2010.03.003. Epub 2010 Mar 31.

PMID:
20359843
37.

The quality of eight health status measures were compared for chronic opioid dependence.

Nosyk B, Sun H, Guh DP, Oviedo-Joekes E, Marsh DC, Brissette S, Schechter MT, Anis AH.

J Clin Epidemiol. 2010 Oct;63(10):1132-44. doi: 10.1016/j.jclinepi.2009.12.003. Epub 2010 Mar 17.

PMID:
20236799
38.

The Andalusian trial on heroin-assisted treatment: a 2 year follow-up.

Oviedo-Joekes E, March JC, Romero M, Perea-Milla E.

Drug Alcohol Rev. 2010 Jan;29(1):75-80. doi: 10.1111/j.1465-3362.2009.00100.x.

PMID:
20078686
39.

Diacetylmorphine versus methadone for the treatment of opioid addiction.

Oviedo-Joekes E, Brissette S, Marsh DC, Lauzon P, Guh D, Anis A, Schechter MT.

N Engl J Med. 2009 Aug 20;361(8):777-86. doi: 10.1056/NEJMoa0810635.

40.

Efficacy of prescribed injectable diacetylmorphine in the Andalusian trial: Bayesian analysis of responders and non-responders according to a multi domain outcome index.

Perea-Milla E, Ayçaguer LC, Cerdà JC, Saiz FG, Rivas-Ruiz F, Danet A, Vallecillo MR, Oviedo-Joekes E.

Trials. 2009 Aug 14;10:70. doi: 10.1186/1745-6215-10-70.

41.

Scientific and political challenges in North America's first randomized controlled trial of heroin-assisted treatment for severe heroin addiction: rationale and design of the NAOMI study.

Oviedo-Joekes E, Nosyk B, Marsh DC, Guh D, Brissette S, Gartry C, Krausz M, Anis A, Schechter MT.

Clin Trials. 2009 Jun;6(3):261-71. doi: 10.1177/1740774509105222.

42.

[Use and evaluation of the health care services and the antirretroviral medication in HIV diagnosed people].

Oviedo-Joekes E, Romero M, Carles March J, López Rus MA, Perea-Milla E; Asociación AVALON.

Gac Sanit. 2009 Mar-Apr;23(2):121-6. doi: 10.1016/j.gaceta.2008.03.005. Epub 2009 Feb 13. Spanish.

43.

[Emotional map in Andalusian primary care teams].

March Cerdá JC, Oviedo-Joekes E, Romero Vallecillos M, Prieto Rodríguez MA, Danet A.

Aten Primaria. 2009 Feb;41(2):69-73. doi: 10.1016/j.aprim.2008.09.007. Epub 2009 Feb 3. Spanish.

44.

NAOMI: The trials and tribulations of implementing a heroin assisted treatment study in North America.

Gartry CC, Oviedo-Joekes E, Laliberté N, Schechter MT.

Harm Reduct J. 2009 Jan 21;6:2. doi: 10.1186/1477-7517-6-2.

45.

The North American Opiate Medication Initiative (NAOMI): profile of participants in North America's first trial of heroin-assisted treatment.

Oviedo-Joekes E, Nosyk B, Brissette S, Chettiar J, Schneeberger P, Marsh DC, Krausz M, Anis A, Schechter MT.

J Urban Health. 2008 Nov;85(6):812-25. doi: 10.1007/s11524-008-9312-9. Epub 2008 Aug 29.

46.

[Spanish adaptation and diagnostic validity of the Yale Global Tics Severity Scale].

García-López R, Perea-Milla E, Romero-González J, Rivas-Ruiz F, Ruiz-García C, Oviedo-Joekes E, de Las Mulas-Bejar M.

Rev Neurol. 2008 Mar 1-15;46(5):261-6. Spanish.

47.

Inconsistent condom use among socially excluded heroin users.

March JC, Oviedo-Joekes E, Romero M.

Gac Sanit. 2007 Jul-Aug;21(4):321-8.

48.

Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics.

Fischer B, Oviedo-Joekes E, Blanken P, Haasen C, Rehm J, Schechter MT, Strang J, van den Brink W.

J Urban Health. 2007 Jul;84(4):552-62. Review.

49.

Compensatory and mimetic conditioned responses to effects of heroin in addicted persons.

Trujillo HM, Oviedo-Joekes E, Vargas C.

Psicothema. 2006 Feb;18(1):59-65.

PMID:
17296010
50.

Factors associated with reported hepatitis C and HIV among injecting drug users in ten European cities.

March JC, Oviedo-Joekes E, Romero M.

Enferm Infecc Microbiol Clin. 2007 Feb;25(2):91-7.

PMID:
17288906

Supplemental Content

Loading ...
Support Center